New scan to see alpha-synuclein in the brain
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study is testing a new imaging scan (18F-CP6A PET) to detect a protein called alpha-synuclein in the brain. If you have Parkinson's disease, multiple system atrophy, or Lewy body dementia, or if you are a healthy volunteer, this scan may help doctors better understand these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old, depending on the group.
- You must be willing to have a PET/MRI or PET/CT scan.
- You cannot be pregnant or breastfeeding, and you must use birth control if needed.
- You should not have other serious brain or chronic diseases.
- You must not have taken part in another clinical trial recently (1 month for healthy, 3 months for patients).
- You must be able to understand and follow the study instructions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a new type of PET scan to look for specific proteins in the brain that are linked to Alzheimer's disease. It will help doctors see how these proteins relate to cognitive decline and compare scans from people with normal thinking to those with memory problems.
This trial uses a special brain scan (PET/CT) to look at a protein called alpha-synuclein in people with Parkinson's disease. The goal is to learn more about the disease and how it affects the brain.
This trial uses a new imaging agent (like a dye) to see signs of Parkinson's disease in the brain. If you have Parkinson's or a related condition like Lewy body dementia or multiple system atrophy, this scan may help researchers better understand these illnesses.
This study uses a new PET scan tracer called [11C]SY08 to take pictures of the brain in people with Parkinson's, multiple system atrophy, or dementia with Lewy bodies. It aims to see if this tracer can help better understand and tell apart these conditions.
This study tests if a new radioactive tracer called [18F]-MFBG can help doctors better distinguish between Parkinson's disease, multiple system atrophy (MSA), dementia with Lewy bodies, and Alzheimer's disease. It compares the new scan with two standard scans to see which is most accurate.
This research study tests a new type of brain scan (called a PET scan) that may help detect early signs of Parkinson's disease and similar conditions. You'll receive the scan and may have a spinal tap to check for specific protein markers.
Hear when a new Synucleinopathies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.